A phase 1 study of intravenously administered TR-701 FA in subjects with advanced renal impairment
Saved in:
| Published in | Critical care (London, England) Vol. 17; no. S3; p. P25 |
|---|---|
| Main Authors | , , , , , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
BioMed Central Ltd
01.01.2013
BioMed Central |
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| ArticleNumber | P25 |
|---|---|
| Author | Flanagan, S Prokocimer, P Morris, D Alcorn, H Marbury, T Fang, E Minassian, SL Boyea, T Dreskin, H Abdelhameed, M |
| AuthorAffiliation | 3 DaVita, Minneapolis, MN, USA 4 Orlando Clinical Research Center, Orlando, FL, USA 1 Trius Therapeutics, San Diego, CA, USA 2 Covance, Madison, WI, USA |
| AuthorAffiliation_xml | – name: 1 Trius Therapeutics, San Diego, CA, USA – name: 3 DaVita, Minneapolis, MN, USA – name: 4 Orlando Clinical Research Center, Orlando, FL, USA – name: 2 Covance, Madison, WI, USA |
| Author_xml | – sequence: 1 givenname: S surname: Flanagan fullname: Flanagan, S – sequence: 2 givenname: D surname: Morris fullname: Morris, D – sequence: 3 givenname: T surname: Boyea fullname: Boyea, T – sequence: 4 givenname: H surname: Dreskin fullname: Dreskin, H – sequence: 5 givenname: SL surname: Minassian fullname: Minassian, SL – sequence: 6 givenname: H surname: Alcorn fullname: Alcorn, H – sequence: 7 givenname: T surname: Marbury fullname: Marbury, T – sequence: 8 givenname: M surname: Abdelhameed fullname: Abdelhameed, M – sequence: 9 givenname: E surname: Fang fullname: Fang, E – sequence: 10 givenname: P surname: Prokocimer fullname: Prokocimer, P |
| BookMark | eNp1kdFLwzAQxoMouE3xX8ibT9Vc0zapD8IYToWBIPO5JOnVZbRpSbrJ_ns7NoZ78OmO-37fB3c3JpeudUjIHbAHAJk9GgNxlsAFGQHPkkimPL3801-TcQhrxkDIjI-IntJupQJSoKHflDvaVtS63qstunYT6h1VZWOdDT16LOnyMxIM6Hw6QDRs9BpNH-iP7VcDt1XODIxHp2pqm05Z36Drb8hVpeqAt8c6IV_zl-XsLVp8vL7PpotIgwCIKs3jinOtJajcGM7QaJVjzmIDSsvKSA1lghKESKVgDJMslmKYYcJ4mgs-Ic-H3G6jGywN7teoi87bRvld0SpbnCvOrorvdltwmUOapkPA0yFA2_afgHPFtE1xPPdgvj-YjW9D8FidfMCK_WNO5C-g7oT- |
| ContentType | Journal Article |
| Copyright | Copyright © 2013 Flanagan et al; licensee BioMed Central Ltd. 2013 Flanagan et al; licensee BioMed Central Ltd. |
| Copyright_xml | – notice: Copyright © 2013 Flanagan et al; licensee BioMed Central Ltd. 2013 Flanagan et al; licensee BioMed Central Ltd. |
| DBID | AAYXX CITATION 5PM |
| DOI | 10.1186/cc12641 |
| DatabaseName | CrossRef PubMed Central (Full Participant titles) |
| DatabaseTitle | CrossRef |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1364-8535 1466-609X |
| EndPage | P25 |
| ExternalDocumentID | PMC3891555 oai_biomedcentral_com_cc12641 10_1186_cc12641 |
| GroupedDBID | --- 0R~ 29F 2WC 4.4 53G 5GY 5VS 6J9 6PF AAFWJ AAJSJ AASML AAWTL AAYXX ACGFS ACJQM ADBBV ADUKV AEGXH AENEX AFPKN AHBYD AHMBA AHSBF AHYZX ALIPV ALMA_UNASSIGNED_HOLDINGS AMKLP AMTXH AOIAM AOIJS BAPOH BAWUL BCNDV BFQNJ BMC C6C CITATION CS3 DIK E3Z EBD EBLON EBS EJD EMOBN F5P GROUPED_DOAJ GX1 H13 HYE IAO IHR INH INR ITC KQ8 OK1 PQQKQ RBZ ROL RPM RSV SJN SMD SOJ SV3 TR2 U2A WOQ YOC -5E -5G -BR 3V. 7X7 88E 8FI 8FJ ABUWG ABVAZ ACRMQ ADINQ AFGXO AFKRA AFNRJ BENPR BPHCQ BVXVI C1A C24 CCPQU FYUFA HMCUK M1P O5R O5S PIMPY PROAC PSQYO UKHRP 5PM |
| ID | FETCH-LOGICAL-b1711-fb32f33bb81a9cc30ecba9e902c1ab8fc8b1d4e817758700e46287b1de4035973 |
| IEDL.DBID | RBZ |
| ISSN | 1364-8535 |
| IngestDate | Thu Aug 21 14:02:43 EDT 2025 Wed May 22 07:14:16 EDT 2024 Tue Jul 01 03:54:26 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | S3 |
| Language | English |
| License | This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-b1711-fb32f33bb81a9cc30ecba9e902c1ab8fc8b1d4e817758700e46287b1de4035973 |
| OpenAccessLink | http://dx.doi.org/10.1186/cc12641 |
| ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_3891555 biomedcentral_primary_oai_biomedcentral_com_cc12641 crossref_primary_10_1186_cc12641 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 20130101 |
| PublicationDateYYYYMMDD | 2013-01-01 |
| PublicationDate_xml | – month: 1 year: 2013 text: 20130101 day: 1 |
| PublicationDecade | 2010 |
| PublicationTitle | Critical care (London, England) |
| PublicationYear | 2013 |
| Publisher | BioMed Central Ltd BioMed Central |
| Publisher_xml | – name: BioMed Central Ltd – name: BioMed Central |
| SSID | ssj0017863 |
| Score | 2.0278313 |
| SourceID | pubmedcentral biomedcentral crossref |
| SourceType | Open Access Repository Index Database |
| StartPage | P25 |
| SubjectTerms | Poster Presentation |
| Title | A phase 1 study of intravenously administered TR-701 FA in subjects with advanced renal impairment |
| URI | http://dx.doi.org/10.1186/cc12641 https://pubmed.ncbi.nlm.nih.gov/PMC3891555 |
| Volume | 17 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LSwMxEA6lgngRn_gsI3gNJptkkz1WsRRBD9JC8VI22YQWyrb0IfjvTdJt7Yonr5vXMrvhyzeT-Qah-ywhwppE4IIZgzktNM65NNiI1LkslbxS-3xLu33-MhCDBrr7O4JPVfpgDPWg7QnOXsI9_AVC_vixDRRIFYulUZZy7JFHrPNidwf-ymSf1ACofhFyB1k6R-iwOhJCe_0Nj1HDlido_7UKep8i3YbZyIMNUIhisDB1MA4zfUZ91ckX5JUCbqi7Cb13LAmFTtt3gsVKB0fLAoK_FTYBf5jbsGLIkBzPg3vwDPU7z72nLq5KI2BNJaXYaZY4xrRWNM-MYcQanWc2I4mhuVbOKE0LbhWVng9IQmxIQZX-meVBs0-yc9Qsp6W9QOB3YJonwlKbE-6sPyAUnrUS59eRRmX6ErGa_YaztQzGMAhT11v8HhlWVr9EsLHydkDkGyr96SJr1q9NXG8px6OofB2CqkKIq3-90jU6SGIti-A_uUHN5Xxlb_2JYqlbkYm34p_1Dcsszzw |
| linkProvider | BioMedCentral |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3LT8IwGG-MJurF-Iz47MFrtV3btTuikaACBwIJ8bKspQ0kZBAeJv73tt1A5tHr-sy3dV-_x-_3AfCQRJgbHXE0pFojRoYKZUxopHlsbRILVrJ9duJmn70P-KCsc-qxMLok-Pd5T4_bCPRJ-G2vs8WKwy7jJ62JU-nO_NkTnAtfwqD7_LkJIwgZSqkRGjPk9BIvULPbA__g3CcV9VRNk9zSO41jcFReGGG92NIJ2DH5KdhvlyHxM6DqcDZyqggSGKhi4dTCsZ_pK7CvTr5hVvLj-qqcsNdFAhPYqLtOcLFS3g2zgN4bC9fpAHBu_IoePzmee-fhOeg3XnsvTVQWTkCKCEKQVTSylColSZZoTbHRKktMgiNNMiWtlooMmZFEOGtBYGw8QFW4Z4Z5Rj9BL8BuPs3NJYDufMZZxA0xGWbWuOvD0Nm02Lp1hJaJqgFakV86K0gyUk9bXW1x7y8tpV4DcC3lzYBgjcj4t4uoSL8ycbUlH48CL7YPuXLOr_61pXtw0Oy1W2nrrfNxDQ6jUPXCe1puwO5yvjK37u6xVHfh-_oBOffdbg |
| linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3JasMwEBUlhdBL6Ur36tCrGsuSLPmYLibdQgkJhF6MJUskNDghS6F_X8l2UrvH3oy1MvJ4NNsbAG5C32Na-QylRClEcSpRQrlCigXGhAGnJdpnN-gM6POQDStZ_KoE-HdxT7fVDPRJ_tu2D-qzNUtNwe0iaCmFrUy3-s82Z4w71uzdfWz8CFzktdQwCSiygokVabPVgX8S3Sc1-VSPk6wInmgP7JY3RtgujngfbOnsADTfSp_4IZBtOBtZWQQxzLFi4dTAsZvpK4dfnXzDpATIdWU5Yb-HuIdh1Lad4GIlnR1mAZ05Fq7jAeBcuxVdAuV47qyHR2AQPfbvO6isnIAk5hgjI4lvCJFS4CRUinhaySTUoecrnEhhlJA4pVpgbtUF7nnaZahy-05TB-nHyTFoZNNMnwBoGTRIfKaxTjxqtL0_pFap9YxdhysRylNAavSLZwVKRuxwq-st9gDjkuqnAK6pvBmQqyMi-O3Ca9SvTVxvycajHBjb-VwZY2f_2tI1aL4_RPHrU_flHOz4edULZ2m5AI3lfKUv7d1jKa_yz-sH1t7dOQ |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=A+phase+1+study+of+intravenously+administered+TR-701+FA+in+subjects+with+advanced+renal+impairment&rft.jtitle=Critical+care+%28London%2C+England%29&rft.au=Flanagan%2C+S&rft.au=Morris%2C+D&rft.au=Boyea%2C+T&rft.au=Dreskin%2C+H&rft.date=2013-01-01&rft.issn=1364-8535&rft.eissn=1364-8535&rft.volume=17&rft.issue=S3&rft_id=info:doi/10.1186%2Fcc12641&rft.externalDBID=n%2Fa&rft.externalDocID=10_1186_cc12641 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1364-8535&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1364-8535&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1364-8535&client=summon |